Research output per year
Research output per year
Personal profile
Research interests
Identifying and improving racial and socioeconomic health disparities in screening, diagnosis, treatment, and outcomes in patients with breast cancer. Circulating tumor DNA, precision medicine, and improving targeted treatment use in patients with metastatic breast cancer.
Clinical interests
Breast cancer, breast oncology, medical oncology
Fingerprint
Dive into the research topics where Emily Podany is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer
Lloyd, M. R., Chica-Parrado, R., Weipert, C. M., Knepper, T. C., Podany, E. L., Napolitano, F., Ye, D., Lin, C. C., Uemoto, Y., Liao, J., Wegrzyn, C., Walko, C. M., Ryan, L. Y., Keenan, J. C., Medford, A. J., Liu, S. A., Wulf, G. M., Clifton, K. K., Ma, C. & Han, H. S. & 6 others, , Aug 2025, In: EBioMedicine. 118, 105828.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
Pontolillo, L., Davis, A. A., Gerratana, L., Medford, A. J., Wang, J., Nicolo’, E., Clifton, K., Velimirovic, M., Warrior, S., Podany, E., Andreopoulou, E., Serafini, M. S., Munoz-Arcos, L., Molteni, E., Lipsyc-Sharf, M., Gianni, C., Bayou, N., Dai, C. S., Giannarelli, D. & Bria, E. & 4 others, , Dec 2025, In: npj Breast Cancer. 11, 1, 93.Research output: Contribution to journal › Article › peer-review
Open Access -
Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms
Hensing, W. L., Podany, E. L., Sears, J. J., Tapiavala, S. & Davis, A. A., 2025, In: Oncotarget. 16, p. 11-27 17 p.Research output: Contribution to journal › Review article › peer-review
Open Access4 Scopus citations -
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
Medford, A. J., Velimirovic, M., Gefen, Y., Niemierko, A., Gerratana, L., Davis, A. A., Clifton, K., Keenan, J., Podany, E., Hensing, W. L., Reduzzi, C., Dai, C. S., Kiedrowski, L. A., Spring, L. M., Ellisen, L. W., Doebele, R. C., Cristofanilli, M., Getz, G. & Bardia, A., Aug 2025, In: Breast Cancer Research and Treatment. 212, 3, p. 437-447 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Molecular and prognostic convergence of HR+/HER2– metastatic breast cancer (MBC) to a TNBC-like profile: Insights from circulating tumor DNA (ctDNA)-based genomic analysis across treatment lines.
Foffano, L., Reduzzi, C., Davis, A. A., Podany, E. L., Medford, A. J., Clifton, K., Velimirovic, M., Putur, A., Pontolillo, L., Tapiavala, S., Molteni, E., Nicolò, E., Pastò, B., Gradishar, W. J., Ma, C. X., Andreopoulou, E., Puglisi, F., Bardia, A., Gerratana, L. & Cristofanilli, M., 2025, In: Journal of Clinical Oncology. 43, 16_suppl, p. 1072 1 p.Research output: Contribution to journal › Article › peer-review